BioNTech SE (BNTX)
85.68
+0.64
(+0.75%)
USD |
NASDAQ |
Nov 13, 16:00
85.60
-0.08
(-0.09%)
After-Hours: 19:59
BioNTech Total Liabilities (Quarterly) : 2.797B for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 2.797B |
| June 30, 2026 | 2.956B |
| March 31, 2026 | 2.738B |
| December 31, 2025 | 3.247B |
| September 30, 2025 | 3.365B |
| June 30, 2025 | 3.677B |
| March 31, 2025 | 2.437B |
| December 31, 2024 | 3.229B |
| September 30, 2024 | 3.668B |
| June 30, 2024 | 3.393B |
| March 31, 2024 | 2.472B |
| December 31, 2023 | 3.049B |
| September 30, 2023 | 2.478B |
| June 30, 2023 | 2.530B |
| Date | Value |
|---|---|
| March 31, 2023 | 1.970B |
| December 31, 2022 | 3.440B |
| September 30, 2022 | 4.207B |
| June 30, 2022 | 4.521B |
| March 31, 2022 | 4.883B |
| December 31, 2021 | 4.477B |
| September 30, 2021 | 6.399B |
| June 30, 2021 | 4.348B |
| March 31, 2021 | 1.980B |
| December 31, 2020 | 1.158B |
| September 30, 2020 | 611.62M |
| June 30, 2020 | 417.26M |
| March 31, 2020 | 311.70M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | 5.872M |
| Moderna, Inc. | 6.631B |
| NuCana Plc | 7.330M |
| Immatics NV | 144.51M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 22.91B |
| Shareholders Equity (Quarterly) | 20.12B |
| Debt to Equity Ratio | 0.0286 |
| Current Ratio | 8.552 |
| Net Debt Paydown Yield | -0.21% |